Table 3.
Performance of the GAD-2 in detecting anxiety disorder among patients in routine care* (N=1 196)
| Cut-point | Sensitivity (%) | Specificity (%) | Correctly classified (%) | LR+ | LR− |
|---|---|---|---|---|---|
| ≥0 | 100 | 0 | 1.42 | 1.00 | 0,00 |
| ≥1 | 88.24 | 35.03 | 35.79 | 1.36 | 0.34 |
| ≥2 | 82.35 | 56.74 | 57.11 | 1.90 | 0.31 |
| ≥3 | 58.82 | 75.66 | 75.42 | 2.42 | 0.54 |
| ≥4 | 11.76 | 87.11 | 86.04 | 0.91 | 1.01 |
| ≥5 | 0 | 94.49 | 93.14 | 0.00 | 1.06 |
| ≥6 | 0 | 96.10 | 94.73 | 0.00 | 1.04 |
| >6 | 0 | 100 | 98.58 | 1.00 | 1.00 |
GAD-2 = Generalized Anxiety Disorder measure; LR+ = likelihood ratio positive; LR− = likelihood ratio negative.
Adult Primary Care assessment by the primary healthcare nurse was used as a diagnostic reference standard.